Protective Effect of Ginkgo Biloba Extract on 5-Fluorouracil-Induced Cardiotoxicity in Rats
Year: 2026
Type: article
Abstract: 5-Fluorouracil (5-FU) is one of the most commonly used chemotherapeutic agents for treating solid tumors, and 5-FU-induced cardiotoxicity is the second leading cause of chemotherapeutic cardiotoxicity. This study evaluated the potential protective effect of different Ginkgo biloba extract (GBE) doses (150 and 300 mg/kg body weight/day) in rats with 5-FU-induced heart damage. Histopathological and immunohistochemical examinations were also performed to assess tissue damage/preservation associated with different GBE dose administrations. 5-FU significantly increased (p < 0.001) serum myocardial damage parameters (aspartate transferase, alanine transaminase, lactate dehydrogenase, creatine kinase-myocardial band, and Troponin-I), malondialdehyde, and Caspase-3 and significantly decreased (p < 0.001) antioxidant parameters (glutathione S-transferases, glutathione reductase, superoxide dismutase, glutathione peroxidase). Histopathological examination revealed that 5-FU caused severe cardiotoxicity, while the use of increasing doses of GBE was associated with a more limited extent of such changes. Similarly, immunopathological analysis showed that 5-FU caused DNA oxidation (8-hydroxydeoxyguanosine) and phosphorylation (γ phosphorylated form of the histone H2AX), and that increasing GBE doses reduced levels of these DNA damage biomarkers. Taken together, these findings suggest that GBE administration may reduce markers of 5-FU-induced cardiac and oxidative damage, with the higher dose eliciting a more pronounced response. However, further experiments are needed to elucidate GBE’s potential effects on 5-FU-induced cardiac damage and the underlying mechanisms.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7235865420
